Annual Net Income
-$76.40 M
+$11.82 M+13.40%
December 31, 2023
Summary
- As of February 8, 2025, XLO annual net profit is -$76.40 million, with the most recent change of +$11.82 million (+13.40%) on December 31, 2023.
- During the last 3 years, XLO annual net income has fallen by -$21.18 million (-38.37%).
- XLO annual net income is now -341.36% below its all-time high of -$17.31 million, reached on December 31, 2019.
Performance
XLO Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$14.02 M
-$95.00 K-0.68%
September 30, 2024
Summary
- As of February 8, 2025, XLO quarterly net profit is -$14.02 million, with the most recent change of -$95.00 thousand (-0.68%) on September 30, 2024.
- Over the past year, XLO quarterly net income has increased by +$3.63 million (+20.59%).
- XLO quarterly net income is now -0.68% below its all-time high of -$13.93 million, reached on June 30, 2024.
Performance
XLO Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$62.80 M
+$2.73 M+4.16%
September 30, 2024
Summary
- As of February 8, 2025, XLO TTM net profit is -$62.80 million, with the most recent change of +$2.73 million (+4.16%) on September 30, 2024.
- Over the past year, XLO TTM net income has increased by +$13.60 million (+17.80%).
- XLO TTM net income is now -323.80% below its all-time high of -$14.82 million, reached on September 30, 2020.
Performance
XLO TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
XLO Net Income Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +13.4% | +20.6% | +17.8% |
3 y3 years | -38.4% | +20.6% | +17.8% |
5 y5 years | - | +20.6% | +17.8% |
XLO Net Income Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -0.8% | +13.4% | -0.7% | +43.0% | at high | +29.8% |
5 y | 5-year | -341.4% | +13.4% | -0.7% | +43.0% | -323.8% | +29.8% |
alltime | all time | -341.4% | +13.4% | -0.7% | +43.0% | -323.8% | +29.8% |
Xilio Therapeutics Net Income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$14.02 M(+0.7%) | -$62.80 M(-4.2%) |
Jun 2024 | - | -$13.93 M(-19.1%) | -$65.53 M(-7.7%) |
Mar 2024 | - | -$17.20 M(-2.6%) | -$70.96 M(-7.1%) |
Dec 2023 | -$76.40 M(-13.4%) | -$17.66 M(+5.4%) | -$76.40 M(-5.9%) |
Sep 2023 | - | -$16.75 M(-13.5%) | -$81.22 M(-3.6%) |
Jun 2023 | - | -$19.36 M(-14.5%) | -$84.26 M(-5.9%) |
Mar 2023 | - | -$22.65 M(+0.8%) | -$89.52 M(+1.5%) |
Dec 2022 | -$88.22 M | -$22.47 M(+13.5%) | -$88.22 M(+3.2%) |
Sep 2022 | - | -$19.79 M(-19.6%) | -$85.46 M(+4.3%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2022 | - | -$24.61 M(+15.3%) | -$81.92 M(+1.8%) |
Mar 2022 | - | -$21.35 M(+8.4%) | -$80.49 M(+6.2%) |
Dec 2021 | -$75.80 M(+37.3%) | -$19.70 M(+21.2%) | -$75.80 M(-1.4%) |
Sep 2021 | - | -$16.25 M(-29.9%) | -$76.87 M(+1.9%) |
Jun 2021 | - | -$23.18 M(+39.1%) | -$75.44 M(+44.4%) |
Mar 2021 | - | -$16.67 M(-19.8%) | -$52.26 M(+46.8%) |
Dec 2020 | -$55.22 M(+219.0%) | -$20.77 M(+40.2%) | -$35.59 M(+140.2%) |
Sep 2020 | - | -$14.82 M | -$14.82 M |
Dec 2019 | -$17.31 M | - | - |
FAQ
- What is Xilio Therapeutics annual net profit?
- What is the all time high annual net income for Xilio Therapeutics?
- What is Xilio Therapeutics annual net income year-on-year change?
- What is Xilio Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Xilio Therapeutics?
- What is Xilio Therapeutics quarterly net income year-on-year change?
- What is Xilio Therapeutics TTM net profit?
- What is the all time high TTM net income for Xilio Therapeutics?
- What is Xilio Therapeutics TTM net income year-on-year change?
What is Xilio Therapeutics annual net profit?
The current annual net income of XLO is -$76.40 M
What is the all time high annual net income for Xilio Therapeutics?
Xilio Therapeutics all-time high annual net profit is -$17.31 M
What is Xilio Therapeutics annual net income year-on-year change?
Over the past year, XLO annual net profit has changed by +$11.82 M (+13.40%)
What is Xilio Therapeutics quarterly net profit?
The current quarterly net income of XLO is -$14.02 M
What is the all time high quarterly net income for Xilio Therapeutics?
Xilio Therapeutics all-time high quarterly net profit is -$13.93 M
What is Xilio Therapeutics quarterly net income year-on-year change?
Over the past year, XLO quarterly net profit has changed by +$3.63 M (+20.59%)
What is Xilio Therapeutics TTM net profit?
The current TTM net income of XLO is -$62.80 M
What is the all time high TTM net income for Xilio Therapeutics?
Xilio Therapeutics all-time high TTM net profit is -$14.82 M
What is Xilio Therapeutics TTM net income year-on-year change?
Over the past year, XLO TTM net profit has changed by +$13.60 M (+17.80%)